Covidien endotracheal tube helps prevent pneumonia
This article was originally published in The Gray Sheet
Executive SummaryCovidien says its Mallinckrodt SealGuard Evac entdotracheal tube, launched Feb. 2 at the Society of Critical Care Medicine Congress in Nashville, is designed to reduce microaspiration of secretions into the lungs by 95% compared with products currently on the market with high-volume, low-pressure cuffs. The device also helps provide secretion drainage through an integrated suction lumen. Last fall, the company announced plans to target high-growth market segments in the respiratory care business, including devices to fight ventilator-associated pneumonia (1"The Gray Sheet" Sept. 15, 2008, p. 13). The product received 510(k) clearance on Oct. 2, 2008
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.